Tauroursodeoxycholic acid

Tauroursodeoxycholic acid is a lipid of Sterol Lipids (ST) class. Tauroursodeoxycholic acid is associated with abnormalities such as Hyperglycemia, Obesity, Wiskott-Aldrich Syndrome, neurogenic hypertension and Cholestatic liver disease. The involved functions are known as Cell Death, Apoptosis, Homeostasis, Process and mRNA Expression. Tauroursodeoxycholic acid often locates in Body tissue, Endoplasmic Reticulum, Hepatic, Blood and Protoplasm. The associated genes with Tauroursodeoxycholic acid are Homologous Gene and Mutant Proteins. The related lipids are cholanic acid, taurolithocholic acid 3-sulfate, Sterols, 7-dehydrocholesterol and tauromuricholic acid. The related experimental models are Disease model.

Cross Reference

Introduction

To understand associated biological information of Tauroursodeoxycholic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Tauroursodeoxycholic acid?

Tauroursodeoxycholic acid is suspected in Endothelial dysfunction, Hyperglycemia, Obesity, neurogenic hypertension, Cholestatic liver disease, Heart failure and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Tauroursodeoxycholic acid

MeSH term MeSH ID Detail
Hypertension D006973 115 associated lipids
Insulin Resistance D007333 99 associated lipids
Total 2

PubChem Associated disorders and diseases

What pathways are associated with Tauroursodeoxycholic acid

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Tauroursodeoxycholic acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Tauroursodeoxycholic acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Tauroursodeoxycholic acid?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Tauroursodeoxycholic acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Tauroursodeoxycholic acid?

Disease model

Disease model are used in the study 'Bile Acids Reduce Prion Conversion, Reduce Neuronal Loss, and Prolong Male Survival in Models of Prion Disease.' (Cortez LM et al., 2015).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Tauroursodeoxycholic acid

Download all related citations
Per page 10 20 50 100 | Total 531
Authors Title Published Journal PubMed Link
pmid:
Eckhardt U et al. Polyspecific substrate uptake by the hepatic organic anion transporter Oatp1 in stably transfected CHO cells. 1999 Am. J. Physiol. pmid:10198348
Funaoka M et al. Tauroursodeoxycholic acid enhances phagocytosis of the cultured rat Kupffer cell. 1999 J. Gastroenterol. Hepatol. pmid:10440209
Hertl M et al. Tauroursodeoxycholate ameliorates reperfusion injury after pig liver transplantation. 1999 Transpl. Int. pmid:10654358
Benz C et al. Effect of tauroursodeoxycholic acid on bile acid-induced apoptosis in primary human hepatocytes. 2000 Eur. J. Clin. Invest. pmid:10691996
Falasca L et al. Tauroursodeoxycholate reduces ischemic damage in human allografts: a biochemical and ultrastructural study. 2000 Transplant. Proc. pmid:10700964
Kurz AK et al. Phosphoinositide 3-kinase-dependent Ras activation by tauroursodesoxycholate in rat liver. 2000 Biochem. J. pmid:10926845
Rodrigues CM et al. Tauroursodeoxycholic acid partially prevents apoptosis induced by 3-nitropropionic acid: evidence for a mitochondrial pathway independent of the permeability transition. 2000 J. Neurochem. pmid:11080188
Rodrigues CM et al. Amyloid beta-peptide disrupts mitochondrial membrane lipid and protein structure: protective role of tauroursodeoxycholate. 2001 Biochem. Biophys. Res. Commun. pmid:11181071
Chignard N et al. Bile acid transport and regulating functions in the human biliary epithelium. 2001 Hepatology pmid:11230727
Milkiewicz P et al. Effect of tauroursodeoxycholate and S-adenosyl-L-methionine on 17beta-estradiol glucuronide-induced cholestasis. 2001 J. Hepatol. pmid:11281545
Ejiri S et al. Cellular distribution of thrombomodulin as an early marker for warm ischemic liver injury in porcine liver transplantation: protective effect of prostaglandin I2 analogue and tauroursodeoxycholic acid. 2001 Transplantation pmid:11330532
Beuers U et al. Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver. 2001 Hepatology pmid:11343250
Moschetta A et al. Hydrophilic bile salts enhance differential distribution of sphingomyelin and phosphatidylcholine between micellar and vesicular phases: potential implications for their effects in vivo. 2001 J. Hepatol. pmid:11394647
Falasca L et al. Protective role of tauroursodeoxycholate during harvesting and cold storage of human liver: a pilot study in transplant recipients. 2001 Transplantation pmid:11397961
Ishizaki K et al. Effect of sodium tauroursodeoxycholate on phalloidin-induced cholestasis in rats. 2001 Eur. J. Pharmacol. pmid:11408049
Calmus Y and Podevin P Tauroursodeoxycholic acid for the cytoprotection of liver grafts during cold storage: a new aspect of its anti-apoptotic properties? 2001 Transplantation pmid:11408962
Fimognari C et al. Micronuclei induction, cell cycle delay and apoptosis as markers of cellular stress caused by ursodeoxycholic acid in human lymphocytes. 2001 Mutat. Res. pmid:11448637
Crocenzi FA et al. Beneficial effects of silymarin on estrogen-induced cholestasis in the rat: a study in vivo and in isolated hepatocyte couplets. 2001 Hepatology pmid:11481618
Moschetta A et al. Cholesterol crystallization in model biles: effects of bile salt and phospholipid species composition. 2001 J. Lipid Res. pmid:11483629
Danchenko E et al. Effect of bile acids on the proliferative activity and apoptosis of rat hepatocytes. 2001 Exp. Toxicol. Pathol. pmid:11484843
Nathanson MH et al. Stimulation of ATP secretion in the liver by therapeutic bile acids. 2001 Biochem. J. pmid:11485545
Kurz AK et al. Tauroursodesoxycholate-induced choleresis involves p38(MAPK) activation and translocation of the bile salt export pump in rats. 2001 Gastroenterology pmid:11487550
Piazza F et al. Competition in liver transport between chenodeoxycholic acid and ursodeoxycholic acid as a mechanism for ursodeoxycholic acid and its amidates' protection of liver damage induced by chenodeoxycholic acid. 2000 Dig Liver Dis pmid:11515630
Keene CD et al. A bile acid protects against motor and cognitive deficits and reduces striatal degeneration in the 3-nitropropionic acid model of Huntington's disease. 2001 Exp. Neurol. pmid:11573988
Asamoto Y et al. Bile-salt hydrophobicity is a key factor regulating rat liver plasma-membrane communication: relation to bilayer structure, fluidity and transporter expression and function. 2001 Biochem. J. pmid:11672435
Colell A et al. Tauroursodeoxycholic acid protects hepatocytes from ethanol-fed rats against tumor necrosis factor-induced cell death by replenishing mitochondrial glutathione. 2001 Hepatology pmid:11679967
Ishigami F et al. Bile salt tauroursodeoxycholic acid modulation of Bax translocation to mitochondria protects the liver from warm ischemia-reperfusion injury in the rat. 2001 Transplantation pmid:11740392
Rodrigues CM et al. Neuroprotection by a bile acid in an acute stroke model in the rat. 2002 J. Cereb. Blood Flow Metab. pmid:11919517
Carubbi F et al. Comparative cytotoxic and cytoprotective effects of taurohyodeoxycholic acid (THDCA) and tauroursodeoxycholic acid (TUDCA) in HepG2 cell line. 2002 Biochim. Biophys. Acta pmid:11923098
Alpini G et al. Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha. 2002 Hepatology pmid:11981754
Graf D et al. Taurolithocholic acid-3 sulfate induces CD95 trafficking and apoptosis in a c-Jun N-terminal kinase-dependent manner. 2002 Gastroenterology pmid:11984527
Veggi LM et al. Dapsone-induced cholestasis and impairment of bile salt output in the rat. 2002 Biochem. Pharmacol. pmid:11996898
Pandak WM et al. Regulation of oxysterol 7alpha-hydroxylase (CYP7B1) in primary cultures of rat hepatocytes. 2002 Hepatology pmid:12029625
Glasova H et al. Tauroursodeoxycholic acid mobilizes alpha-PKC after uptake in human HepG2 hepatoma cells. 2002 Eur. J. Clin. Invest. pmid:12059989
Xiao ZL et al. Effects of bile acids on the muscle functions of guinea pig gallbladder. 2002 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:12065295
Duan WM et al. Tauroursodeoxycholic acid improves the survival and function of nigral transplants in a rat model of Parkinson's disease. 2002 Cell Transplant pmid:12075985
Milkiewicz P et al. Hepatoprotection with tauroursodeoxycholate and beta muricholate against taurolithocholate induced cholestasis: involvement of signal transduction pathways. 2002 Gut pmid:12077103
Azzaroli F et al. Ursodeoxycholic acid diminishes Fas-ligand-induced apoptosis in mouse hepatocytes. 2002 Hepatology pmid:12085348
Kim YH and Shin MJ Effects of high taurocholate load on activities of hepatic alcohol metabolizing enzymes. 2002 Exp. Mol. Med. pmid:12085987
Venneman NG et al. Effects of hydrophobic and hydrophilic bile salt mixtures on cholesterol crystallization in model biles. 2002 Biochim. Biophys. Acta pmid:12117566
Keene CD et al. Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease. 2002 Proc. Natl. Acad. Sci. U.S.A. pmid:12149470
Yamashita Y et al. High metabolic function of primary human and porcine hepatocytes in a polyurethane foam/spheroid culture system in plasma from patients with fulminant hepatic failure. 2002 Cell Transplant pmid:12162378
Heubi JE et al. Tauroursodeoxycholic acid (TUDCA) in the prevention of total parenteral nutrition-associated liver disease. 2002 J. Pediatr. pmid:12183720
Xie Q et al. Effect of tauroursodeoxycholic acid on endoplasmic reticulum stress-induced caspase-12 activation. 2002 Hepatology pmid:12198651
Piepoli AL et al. Tauroursodeoxycholic acid reduces damaging effects of taurodeoxycholic acid on fundus gastric mucosa. 2002 Arch. Physiol. Biochem. pmid:12221520
Kok T et al. Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice. 2003 Biochem. J. pmid:12381268
Noé J et al. Functional expression of the canalicular bile salt export pump of human liver. 2002 Gastroenterology pmid:12404240
Chignard N et al. Bile salts potentiate adenylyl cyclase activity and cAMP-regulated secretion in human gallbladder epithelium. 2003 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:12421748
Lamireau T et al. Effects of bile acids on biliary epithelial cells: proliferation, cytotoxicity, and cytokine secretion. 2003 Life Sci. pmid:12527037